# IC14 for Treatment of Amyotrophic Lateral Sclerosis

> **NCT03508453** · PHASE2 · WITHDRAWN · sponsor: **Implicit Bioscience**

## Conditions studied

- Amyotrophic Lateral Sclerosis
- Motor Neuron Disease

## Interventions

- **BIOLOGICAL:** IC14
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03508453
- **Lead sponsor:** Implicit Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-08-15
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled in study
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03508453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03508453, "IC14 for Treatment of Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03508453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*